Brighton Jones’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $709K | Sell |
8,219
-17
| -0.2% | -$1.51K | 0.01% | 651 |
|
|
2026
Q2 | $745K | Sell |
8,236
-1,984
| -19% | -$166K | 0.01% | 620 |
|
|
2026
Q1 | $818K | Buy |
+10,220
| New | +$843K | 0.02% | 528 |
|
|
2025
Q4 | – | Sell |
-10,833
| Closed | -$842K | – | 342 |
|
|
2025
Q3 | $842K | Buy |
10,833
+5,648
| +109% | +$441K | 0.02% | 450 |
|
|
2025
Q2 | $406K | Buy |
5,185
+805
| +18% | +$60K | 0.01% | 603 |
|
|
2025
Q1 | $317K | Buy |
4,380
+793
| +22% | +$56.8K | 0.01% | 518 |
|
|
2024
Q4 | $266K | Buy |
+3,587
| New | +$251K | 0.01% | 555 |
|
|
2024
Q3 | – | Sell |
-3,742
| Closed | -$346K | – | 610 |
|
|
2024
Q2 | $346K | Buy |
3,742
+339
| +10% | +$30K | 0.01% | 440 |
|
|
2024
Q1 | $325K | Buy |
3,403
+222
| +7% | +$18.6K | 0.01% | 441 |
|
|
2023
Q4 | $243K | Sell |
3,181
-25
| -0.8% | -$1.74K | 0.01% | 490 |
|
|
2023
Q3 | $222K | Sell |
3,206
-184
| -5% | -$14.8K | 0.01% | 477 |
|
|
2023
Q2 | $320K | Buy |
3,390
+576
| +20% | +$50.1K | 0.02% | 382 |
|
|
2023
Q1 | $233K | Buy |
+2,814
| New | +$221K | 0.01% | 434 |
|
|
2022
Q4 | – | Sell |
-2,462
| Closed | -$203K | – | 491 |
|
|
2022
Q3 | $203K | Buy |
2,462
+74
| +3% | +$7.12K | 0.01% | 421 |
|
|
2022
Q2 | $227K | Buy |
2,388
+57
| +2% | +$5.9K | 0.01% | 396 |
|
|
2022
Q1 | $274K | Buy |
2,331
+90
| +4% | +$10.1K | 0.01% | 387 |
|
|
2021
Q4 | $290K | Buy |
2,241
+29
| +1% | +$3.38K | 0.01% | 383 |
|
|
2021
Q3 | $250K | Buy |
2,212
+62
| +3% | +$7.08K | 0.01% | 400 |
|
|
2021
Q2 | $223K | Buy |
+2,150
| New | +$203K | 0.01% | 431 |
|
|
2020
Q4 | – | Sell |
-3,039
| Closed | -$243K | – | 397 |
|
|
2020
Q3 | $243K | Buy |
3,039
+63
| +2% | +$4.92K | 0.02% | 284 |
|
|
2020
Q2 | $206K | Sell |
2,976
-282
| -9% | -$20K | 0.02% | 274 |
|
|
2020
Q1 | $205K | Buy |
3,258
+24
| +0.7% | +$1.73K | 0.02% | 256 |
|
|
2019
Q4 | $251K | Sell |
3,234
-108
| -3% | -$8.43K | 0.03% | 279 |
|
|
2019
Q3 | $245K | Buy |
+3,342
| New | +$235K | 0.03% | 256 |
|
|
2019
Q2 | – | Sell |
-3,579
| Closed | -$228K | – | 314 |
|
|
2019
Q1 | $228K | Buy |
+3,579
| New | +$204K | 0.03% | 273 |
|
Other funds holding EW
Brighton Jones's EW Position: Q3 2026 in Review
Brighton Jones reduced its Edwards Lifesciences (EW) stake by 0.21% in Q3 2026, selling an estimated $1.51K and leaving 8,219 shares worth $709K. The position accounts for 0.01% of the portfolio, ranked #651.
Brighton Jones first reported a position in EW in Q1 2019 and has held it in 25 quarters since. The position peaked at $842K in Q3 2025. 1,164 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Brighton Jones held 8,219 shares of Edwards Lifesciences worth $709K as of Q3 2026.
- Brighton Jones sold 17 Edwards Lifesciences shares in Q3 2026, an estimated $1.51K.
- Edwards Lifesciences made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #651 holding.
- Brighton Jones first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 25 quarters since.
- Brighton Jones's Edwards Lifesciences position peaked at $842K in Q3 2025.
- 1,164 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.